
Sign up to save your podcasts
Or


No discussion regarding the future is complete unless AI is incorporated.
In this episode, Konstantina Katcheves of Teva Pharmaceuticals and Sanskriti Thakur of TOWER Capital Group provide their insights on the impact of not only the benefits of the technology but the regulatory challenges and uncertainty surrounding AI.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital
By BioSpace4.9
1313 ratings
No discussion regarding the future is complete unless AI is incorporated.
In this episode, Konstantina Katcheves of Teva Pharmaceuticals and Sanskriti Thakur of TOWER Capital Group provide their insights on the impact of not only the benefits of the technology but the regulatory challenges and uncertainty surrounding AI.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital

91,061 Listeners

30,731 Listeners

43,539 Listeners

8,784 Listeners

978 Listeners

4,380 Listeners

1,175 Listeners

1,986 Listeners

56,846 Listeners

9,564 Listeners

338 Listeners

6,125 Listeners

6,581 Listeners

34 Listeners

21 Listeners